# Nutcracker Therapeutics funding: rounds and investors

> Nutcracker Therapeutics has raised $167M across 1 round since 2022. Investors include ARCH Venture Partners. Every round with its source.

Source: https://millionrounds.com/company/nutcracker-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Series C startup](https://millionrounds.com/companies)

# Who invested in *Nutcracker Therapeutics*

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summary Updated 26 Oct 2026

**$167M** raised across 1 round since 2022, from 1 source

- **Latest round:** Series C, $167M Mar 2022
- **Investors:** 1

See who backed them

## The rounds

- **Mar 2022** Series C **$167M** [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) Source recorded

## Founders and team

From the SEC filings it signed: 5 on the team.

- **Benjamin Eldridge** Executive Officer i
- **Igor Khandros** Executive Officer, Director i
- **James Zhu** Executive Officer i
- **Madhavan Balachandran** Executive Officer i
- **Samuel Deutsch** Executive Officer i

On the board, as filed i *Robert Nelsen*

## Everyone who backed them

[ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=nutcracker-therapeutics).

## Quick answers about Nutcracker Therapeutics

### Who invested in Nutcracker Therapeutics?

Nutcracker Therapeutics's investors include ARCH Venture Partners.

### How much has Nutcracker Therapeutics raised?

Nutcracker Therapeutics has raised $167M across 1 round since 2022.

### When did Nutcracker Therapeutics last raise?

Nutcracker Therapeutics's most recent round was a Series C of $167M in Mar 2022.

### What was Nutcracker Therapeutics's biggest round?

Its most recent round, $167M in Mar 2022, is also its largest on record.

### Who backed Nutcracker Therapeutics first?

Nutcracker Therapeutics's first round on record, in Mar 2022, was backed by ARCH Venture Partners.

### What stage is Nutcracker Therapeutics at?

Nutcracker Therapeutics's latest named round is a Series C, in Mar 2022.

### Where is Nutcracker Therapeutics based?

Nutcracker Therapeutics is based in the United States.

## Companies like Nutcracker Therapeutics

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
